AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

China has announced a flurry of retaliatory measures against the U.S., including tariffs on imports of products such as coal, ...

Legal weed, more money for Pennsylvania's poorest schools will likely be in Shapiro’s budget pitch Vladimir Putin is nervous.

SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ ... buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged ...

HONG KONG/SHANGHAI -- China on Friday announced that its economic growth rate for 2024 was in line with the target set by a government beset by the threat of fresh U.S. tariffs, an enduring ...

AstraZeneca (NASDAQ:AZN) has changed several key management positions in its China business as the Anglo-Swedish drugmaker looks to boost its sales following the recent detention of its President ...

AstraZeneca has promoted Mary Guan, previously from its general medicines unit, to head the oncology division in China AstraZeneca has acknowledged cooperating fully with Chinese authorities but ...

Analysts say they see signs of malaise in China’s domestic economy, but those problems were offset mainly by robust exports and a $1 trillion trade surplus. By Keith Bradsher Reporting from ...

(Reuters) -AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general manager, the Financial Times reported on Friday, citing two people ...

TAIPEI, Taiwan -- China's population fell last year for the third straight year, its government said Friday, pointing to further demographic challenges for the world's second most populous nation ...